Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    URB597
Previous Study | Return to List | Next Study

Evaluation Study of New Compounds With Potential Use in Schizophrenia (EICAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00916201
Recruitment Status : Not yet recruiting
First Posted : June 9, 2009
Last Update Posted : August 14, 2019
Sponsor:
Collaborator:
Max-Planck Institute for Metabolism Research
Information provided by (Responsible Party):
F Markus Leweke, Central Institute of Mental Health, Mannheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : December 2022